Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology
Back

Tag: ASCO GU21

Concordance of BRCA1, BRCA2 (BRCA), and ATM mutations identified in matched tumor tissue and circulating tumor DNA (ctDNA) in men with metastatic castration-resistant prostate cancer (mCRPC) screened in the PROfound study

Adverse pathology as a predictor of distant metastasis and prostate cancer mortality with 20-year follow up

MRI-guided fusion biopsy of the prostate resection bed among post-radical prostatectomy patients with rising PSA